OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access
Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants
Soojeong Chang, Jieun Shin, Seowoo Park, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Soojeong Chang, Jieun Shin, Seowoo Park, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Vaccine (2025) Vol. 54, pp. 126960-126960
Closed Access
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Vaccine (2025) Vol. 54, pp. 126960-126960
Closed Access
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice
Diana Lee, Arshan Nasir, Sayda M. Elbashir, et al.
Vaccine (2025) Vol. 54, pp. 126961-126961
Open Access
Diana Lee, Arshan Nasir, Sayda M. Elbashir, et al.
Vaccine (2025) Vol. 54, pp. 126961-126961
Open Access
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access | Times Cited: 1
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access | Times Cited: 1
Structural Immunology of SARS ‐CoV ‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 1
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 1
Macromolecular interaction mechanism of the bacteriocin EntDD14 with the receptor binding domain (RBD) for the inhibition of SARS-CoV-2 and the JN.1 variant: Biomedical study based on elastic networks, stochastic Markov models, and macromolecular volumetric analysis
Luis Moncayo-Molina, María Erlinda Aguaiza Pichazaca, José Suárez Padilla, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107388-107388
Closed Access
Luis Moncayo-Molina, María Erlinda Aguaiza Pichazaca, José Suárez Padilla, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107388-107388
Closed Access
